TrialInternational journal of cancer2020

A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma.

Elizabeth C Lewis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.